CASE CCC IN THE NEWS
Cleveland Clinic Genetics Expert Continues Research with Ex-OSU Colleagues; Team gets $11 million grant
Plain Dealer - Sept 9, 2013
Dr. Charis Eng, chairwoman and founder of the Cleveland Clinic's Genomic Medicine Institute, is leading up a portion of thyroid cancer research that is getting $11.3 million over five years.
Valerie Harper's Cancer Comeback: From Terminal Diagnosis to 'Dancing with the Stars'
Fox News - Sept 4, 2013
Despite a diagnosis of terminal cancer, actress Valerie Harper is now engaged in four-hour-a-day dance rehearsals in preparation for "Dancing with the Stars," according to People magazine. Though Harper's comeback is rare, Dr. Lisa Rachel Rogers, medical director of the neuro-oncology program at University Hospital's Case Medical Center in Cleveland, said it's not entirely unheard of for patients with Harper's disease.
Early Intervention Prolonged Time to Progression in Smoldering Myeloma
Helio/HemOnc Today - Aug 14, 2013
Dr. Frederic Reu discusses results from smoldering multiple myeloma clinical trial.
Clinical and Translational Science Collaborative Annual Pilot Awards
Congratulations to the six faculty members and researchers who were awarded the 2013 Clinical & Translational Science Collaborative's annual pilot awards.
- Micheala Aldred: New therapeutic approaches in Pulmonary Arterial Hypertension
- Matthew Cooney: Evaluation of alpha-methylacyl-CoA racemase (AMACR) as a Non-Invasive Diagnostic Biomarker for Prostate Cancer
- Efstathios Karathanasis: Early Detection of Micrometastasis Using a Nanochain and MRI
- John Kirwan: Unlocking the Mechanisms of Type 2 Diabetes Remission After Gastric Bypass: Relationship Between Stimulus Secretion Coupling Mechanism, Beta Cell Morphology, and Incretin Secretion
- Li Li: Human Beta-Defensin-3 (hBD-3): A Novel Biomarker for Early Colon Neoplasia
- Ann Williams: Diabetes SystemCHANGE(TM): Community-based peer support for people with diabetes
Database of Potential Student Lab Assistants
The Cancer Center has a database of undergraduate and graduate students who are interested in working in cancer research labs or are doing rotations for the Biomedical Sciences Training Program (BSTP). If you are interested in hosting a student volunteer, employee, or rotation, please contact Lyn Haselton at email@example.com. We appreciate your support and interest in training the next generation of cancer researchers!
MARK YOUR CALENDARS
PET/MR Workshop: What You Need to Know
The Department of Radiology is hosting PET/MR Workshop: What You Need to Know on September 13 from 8-5 pm in BRB 105. This symposium brings together some of the pioneers in the novel field of PET-MR Imaging using a practical approach to share the initial clinical experience of this new modality combining the expertise of MR and nuclear medicine images. The target audience for this CME event includes radiologists, nuclear medicine physicians, oncologists, cardiovascular and neurological specialists, primary care physicians and technologists.
MetroHealth Research Symposium
The annual MetroHealth Research Symposium will be held Wednesday, September 18 from 8 am - 6 pm. Activities include poster displays, an oral presentation competition, a poster presentation competition and a keynote address.
The Keynote Speaker, Tony Wynshaw-Boris, MD, PhD, is Chair of Genetics and Genome Sciences at CWRU. He will present his talk, Neurogenetic diseases: From pathogenesis to therapeutics at 5 pm in Rammelkamp 170.
This entire symposium is open to everyone in the community, and would be of particular interest to students, fellows, and scientific and medical professionals. No registration is required. Contact Cindy Pollak at firstname.lastname@example.org or 216-778-8718 for more information.
Point of Care Technologies for Cancer
The National Institutes of Health is hosting a conference on Cancer Technologies, October 7-9, on the NIH campus in Bethesda, Maryland. The conference, Point of Care Technologies for Cancer, is co-sponsored by National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering. The main goal of the conference is to facilitate new scientific collaborations and interactions among cancer researchers and bioengineers, and to build new research programs in this important field in order to promote the translation of new technologies into clinical applications.
In addition to the main conference on October 8-9, there will be a pre-conference symposium on October 7 on Cancer Detection, Diagnostics and Treatment Technologies for Global Health sponsored by the NCI Center for Global Health. The pre-conference will be especially relevant for those interested in global health, since it will focus on the development of cancer-relevant technologies suitable for environments with limited resources. NCI is also targeting this topic area through a new global health funding initiative.
Although there is no registration fee, there are limited seats and all attendees are required to register.
American Skin Association
The American Skin Association is accepting applications for the following funding opportunities. Please note that a Chair can endorse only one Scholar Award (either category) and one research grant each year.
- The Research Scholar Award in Melanoma/Non-Melanoma Skin Cancer seeks to foster the career development of a young investigator working at the level of instructor through associate professor in the field of dermatology or cutaneous biology. The aim of the program is to provide bridge support for young investigators. Special consideration will be given to individuals without significant prior support.
Deadline: October 1
- Support is available for disease-specific research targeting the following five (5) disorders: Childhood Skin Diseases/Disfigurement, Psoriasis/Inflammatory Skin Diseases, Skin Cancer, Melanoma, Vitiligo/Pigment Cell Disorders, and Quality of Life/Health Services/Outcome Studies. There is no age requirement. However, applicants without prior funding, who are in a formative stage of their career, or who are undergoing a mid-career research change will be given preference.
Deadline: October 1
- Funding is available to medical students working actively in the areas of melanoma and skin cancer. Funds may be used for support of a new or ongoing research/clinical investigation project.
Deadline: October 1
Limited Submission: NSF Major Research Instrumentation Program
The Major Research Instrumentation Program (MRI) seeks to improve the quality and expand the scope of research and research training in science and engineering, by supporting proposals for shared instrumentation that fosters the integration of research and education in research-intensive learning environments. Each MRI proposal may request support for the acquisition (Track 1) or development (Track 2) of a single research instrument for shared inter- and/or intra-organizational use; development efforts that leverage the strengths of private sector partners to build instrument development capacity at MRI submission-eligible organizations are encouraged.
To accomplish the program's goals, the MRI program assists with the acquisition or development of a shared research instrument that is, in general, too costly and/or not appropriate for support through other NSF programs. The instrument is expected to be operational for regular research use by the end of the award period.
Internal Deadline: October 14
External Deadline: January 23, 2014